XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (9,071,584) $ (12,009,982)
Adjustment to reconcile net income to net cash used in operating activities:    
Depreciation and amortization 1,786,068 2,609,191
Asset impairments 3,922,110
Goodwill impairment 7,594,000
Amortization of debt issuance costs and accretion of debt discount 39,965 46,883
Non-cash operating lease expense amortization 8,746 (5,377)
Equity based compensation expense 533,631 875,106
Equity based payments to service providers 324,477 397,049
Recognition and change in fair value of warrant liability (156,000) (5,503,647)
Earn-out fair value and write-off adjustments 47,761 1,716,873
Change in operating assets and liabilities:    
Accounts receivable (161,450) (304,542)
Accounts receivable, related parties (1,209) 11,689
Other receivables (41,286) 10,565
Prepaid expense and other current assets (127,739) 104,590
Other non-current assets (1,500) 2,992
Accounts payable and other accrued liabilities 351,486 (48,266)
Other payables 31,400 (93,699)
Net cash used in continuing operating activities (2,515,124) (4,596,575)
Net cash adjustments for discontinued operating activities 3,748,605
Total net cash used in continuing and discontinued operating activities (2,515,124) (847,970)
CASH FLOWS FROM INVESTING ACTIVITIES:    
    Proceeds from sale of investment in NSURE 900,000
Purchase of property and equipment (24,257) (22,864)
Purchase of intangibles (58,971) (166,947)
Net cash (used in) provided by investing activities (83,228) 710,189
CASH FLOWS FROM FINANCING ACTIVITIES:    
Principal repayments of debt (1,397,383) (1,090,622)
Proceeds from short term financings 199,948 241,975
Principal repayments of short-term financings (197,316) (322,095)
Payments of loans payable, related parties (661,253) (1,045,164)
Payments of earn-out liabilities (419,225)
Proceeds from exercise of warrants into common stock 1,028,270
Payments of convertible debt, related parties (855,000)
Proceeds from common shares issued through an at the market offering 3,713,139
Private placement of shares and warrants 3,446,484
Net cash provided by continuing financing activities 1,657,135 984,623
Net cash used in discontinued financing activities (17,700)
Total net cash provided by continuing and discontinued financing activities 1,657,135 966,923
Net (decrease) increase in cash and restricted cash (941,217) 829,142
Cash and restricted cash at beginning of year 2,738,911 1,909,769
Cash and restricted cash at end of year 1,797,694 2,738,911
SUPPLEMENTAL DISCLOSURE OF CASH AND NON-CASH TRANSACTIONS:    
Interest 1,580,686 1,612,829
Noncash investing and financing transactions:    
Common shares issued to settle convertible debt, related parties 645,000
Common shares issued for earnout liabilities 17,628 3,001,045
Common shares issued for Series B warrants 112,666 660,510
Common stock issued for pre-paid assets 192,811
Common shares issued for an acquisition prepayment 329,432
Lease assets acquired in exchange for lease liabilities $ 489,634 $ 156,542